Company page

Amicogen, Inc.

Amicogen, Inc. is a public company traded under the ticker 092040 on the Korean market. The company has a market capitalization of approximately 76.3 million USD. Amicogen focuses on biotechnology and biopharmaceuticals, contributing to advancements in the healthcare sector.